Evercore ISI Group analyst Jonathan Miller initiates coverage on ProKidney (NASDAQ:PROK) with a Outperform rating.
Evercore ISI Group Initiates Coverage On ProKidney with Outperform Rating
Evercore ISI Group analyst Jonathan Miller initiates coverage on ProKidney (NASDAQ:PROK) with a Outperform rating.
Related Posts
Barclays Maintains Overweight on Datadog, Lowers Price Target to $110
Barclays analyst Raimo Lenschow maintains Datadog (NASDAQ:DDOG) with a Overweight and lowers the price target from $130 to $110.
Over $1.6M Crypto Shorts Liquidated In An Hour As Bitcoin, Ethereum Spike
As the prices of Bitcoin (CRYPTO: BTC) and Ethereum (CRYPTO: ETH) shot up in the early hours of Tuesday, $1.65 million worth of cryptocurrency shorts were liquidated.
Adaptive Biotechnologies Revises FY21 Sales Guidance From $145M-$155M To $148M-$155M vs $150.16M Est.
Adaptive Biotechnologies expects full year 2021 revenue to be in the range of $148 million to $155 million, representing 54% growth at the mid-point of the range over full year 2020 revenue. This compares to Adaptive